Clinical Trials Browser

Withdrawn × Panitumumab × Clear all

NCT03069950 2019-05-21

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

Phase 2 Withdrawn

Gastrointestinal

Colorectal Adenocarcinoma Metastatic to the Liver

NCT01634880 2016-05-23

Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies

Phase 2 Withdrawn

Salivary Gland Malignancy

NCT01312493 2015-08-28

Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

Phase 2 Withdrawn

Head and Neck Neoplasms

NCT01130701 2015-03-17

PMABIIS

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT01172717 2013-07-26

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Phase 2 Withdrawn

Carcinoid Tumor, Serotonin Syndrome

NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Phase 3 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00346099 2008-01-07

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

Phase 2 Withdrawn

Gastrointestinal

Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms